Deed of Termination and Release dated November 13, 2008, with Molecular Vision
Deed of Termination and Release
of a Development Agreement relating to the
development of intellectual property by
Molecular Vision Limited
(1) | Molecular Vision Limited |
and
(2) | Acrongenomics Inc |
Dated 2008
Osborne Clarke | |
Apex Plaza | |
Forbury Road | |
Reading | |
RG1 1AX | |
Telephone +44 (0) 118 ###-###-#### | |
Fax +44 (0) 118 ###-###-#### |
This Deed of termination and release is made on 2008
Between:
(1) | Molecular Vision Limited (registered in England under number ###-###-####) whose registered office is at BioIncubator Unit, Bessemer Building, Prince Consort Road, London SW7 2BP Limited ("Molecular Vision"); and |
(2) | Acrongenomics Inc., whose registered office is at 14 Rue Kleberg, Geneva CH-1201, Switzerland ("Acrongenomics"). |
(3) |
(the "Parties")
Whereas:
(A) | The parties entered into a letter agreement dated 19 August 2008 (the "Letter Agreement") relating to the termination of a development agreement between the parties dated 23rd May 2007 (the "Development Agreement") and this Agreement is the definitive agreement contemplated by paragraph 11 of the Letter Agreement relating to the release of obligations and liabilities under the Development Agreement. |
(B) | The Development Agreement terminated on 19 August 2008 |
(C) | Upon the terms of this Deed, the parties have agreed to acknowledge the termination of the Development Agreement and to release and discharge each other from all obligations under it. |
It is agreed as follows:
1. | Termination and Release | |
The Parties agree that: | ||
(a) | the Development Agreement terminated on 19 August 2008 and thereafter ceased to have effect from that date; | |
(b) | each of them shall with effect from such termination stand unconditionally and irrevocably released and discharged from all obligations (past, present and future) arising under or resulting from the Development Agreement; and | |
(c) | neither party shall be entitled to exercise any rights or make any claim counterclaims, or appeal against the other under or in relation to the Development Agreement or its termination. | |
2. | General |
2.1 | Counterparts | |
(a) | This Deed may be executed in any number of counterparts and by the parties on separate counterparts (which may be fax copies), but shall not be effective until each party has executed at least one counterpart. | |
(b) | Each counterpart, when executed, shall be an original of this Deed and all counterparts shall together constitute one instrument. | |
3. | Exclusion of third party rights | |
Unless expressly provided in this Deed, no express term of this Deed is enforceable pursuant to the Contracts (Rights of Third Parties) Act 1999 by any person who is not a party to it. | ||
4. | Governing law and jurisdiction | |
4.1 | Governing law | |
This Deed shall be governed by and construed in accordance with English law. | ||
4.2 | Jurisdiction | |
Each of the parties irrevocably submits for all purposes in connection with this Deed to the exclusive jurisdiction of the courts of England and Wales. |
In witness whereof this Deed has been executed and delivered as a deed on the date written at the beginning of this Deed.
Executed as a Deed by | ) | |
Molecular Vision Limited | ) | |
acting by a director and its | ) | |
secretary or two directors: | ) | |
Director | ||
Director/Secretary | ||
Executed as a Deed by | ) | |
Acrongenomics Inc | ) | |
acting by a director and its | ) | |
secretary or two directors: | ) | |
Director | ||
Director/Secretary |